69. How is AI changing biotech? Interview with Guru Singh (Founder/CEO of Scispot)
Mon Dec 08 2025
This episode dives into the fascinating intersection of biotech, AI, and automation with Mr. Guru Singh, CEO/Founder of Scispot and Y Combinator alumnus.
Learn how a data-driven, autonomous lab future is taking shape.
Could labs run by AI agents and robots cure cancer and revolutionize manufacturing within a decade, and what role does critical thinking play in the AI era?
✅ The Digital Brain of the Lab: Discover how Scispot is building an operating layer to connect siloed data, turning life science labs into autonomous, data-driven research centers.
🎯 AI’s Shifting Value: Understand why execution is getting easier and how critical thinking and life experience are now the key differentiators for success in the AI-accelerated tech world.
💡 Human Augmentation vs. Fixing: Explore the visionary shift in healthcare from reactive treatment (fixing) to proactive strategies focused on human augmentation and maximizing potential.
🧪 Industrializing Biology: Hear the prediction that much of what we use, from medicine to material goods, will be manufactured biologically in labs, driving a multi-trillion-dollar bioeconomy.
🚀 Entrepreneurial Wisdom: Gain insight into the crucial lesson of maintaining focus on the "promised land" and avoiding decisions driven by anxiety in the face of constant entrepreneurial challenges.
Additional resources:
💡 Learn more about Guru's work at Scispot - Scispot.com
✅ Connect/follow Guru on LinkedIn https://www.linkedin.com/in/iamguru/
🎧 Check out Guru’s podcast - talk is biotech! https://www.talkisbiotech.com/
🎧 Listen to this episode on The Wall Street Vision Podcast.
Disclaimer: This podcast is not associated with any financial institution. The views and opinions expressed by the host and podcast guests are their own and do not reflect the opinions of any financial institution. The content provided in this podcast is for informational purposes only and should not be considered tax, financial or investment advice.
More
This episode dives into the fascinating intersection of biotech, AI, and automation with Mr. Guru Singh, CEO/Founder of Scispot and Y Combinator alumnus. Learn how a data-driven, autonomous lab future is taking shape. Could labs run by AI agents and robots cure cancer and revolutionize manufacturing within a decade, and what role does critical thinking play in the AI era? ✅ The Digital Brain of the Lab: Discover how Scispot is building an operating layer to connect siloed data, turning life science labs into autonomous, data-driven research centers. 🎯 AI’s Shifting Value: Understand why execution is getting easier and how critical thinking and life experience are now the key differentiators for success in the AI-accelerated tech world. 💡 Human Augmentation vs. Fixing: Explore the visionary shift in healthcare from reactive treatment (fixing) to proactive strategies focused on human augmentation and maximizing potential. 🧪 Industrializing Biology: Hear the prediction that much of what we use, from medicine to material goods, will be manufactured biologically in labs, driving a multi-trillion-dollar bioeconomy. 🚀 Entrepreneurial Wisdom: Gain insight into the crucial lesson of maintaining focus on the "promised land" and avoiding decisions driven by anxiety in the face of constant entrepreneurial challenges. Additional resources: 💡 Learn more about Guru's work at Scispot - Scispot.com ✅ Connect/follow Guru on LinkedIn https://www.linkedin.com/in/iamguru/ 🎧 Check out Guru’s podcast - talk is biotech! https://www.talkisbiotech.com/ 🎧 Listen to this episode on The Wall Street Vision Podcast. Disclaimer: This podcast is not associated with any financial institution. The views and opinions expressed by the host and podcast guests are their own and do not reflect the opinions of any financial institution. The content provided in this podcast is for informational purposes only and should not be considered tax, financial or investment advice.